Dade Behring Scientists Cited for Receiving U.S. Patents.DEERFIELD, Ill. -- During the year 2003, Dade Behring (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DADE) scientists and their external cooperation partners received twenty-two patents from the U.S. patent office for their inventions, created in the course of working on new product developments for the company's automated in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic analyzers and reagents. Dade Behring is the world's largest company dedicated solely to clinical diagnostics. "Patents represent what our company is all about, outstanding innovation targeted directly at our customers' needs," said Jim Reid-Anderson, Chairman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Dade Behring. "We recognize these individuals as brilliant entrepreneurs and innovators who are actively contributing to driving the company's future, and helping to improve health care for patients everywhere." The patents and their recipients are as follows: --Bill Dunfee, Dan Gillund, Dave Thompson, Tumkur Vijay for their work on a Bi-directional magnetic sample rack conveying system; --Bill Dunfee, Ed Farina, Bruce Gemmell, Ed Kaminski for their work on a Method for maintaining test accuracy within a microbiological test array; --Bill Dunfee, Ed Farina, Bruce Gemmell, Ed Kaminski, Frank Krufka for their work on a Method for minimizing optical interference during antibiotic susceptibility readings in a microbiological analyzer; --Ed Farina, Sam Ferguson, Pete Gebrian, Frank Krufka, Mike Shmel for their work on liquid flow and control in a biological test array; --Ed Farina, Pete Gebrian, Bruce Gemmell, Mike Shmel, Hem Vaidya vaidya /vai·dya/ (vi´dyah) [Sanskrit "one who knows"] in ayurveda, a physician. for their work on an Automated random access microbiological analyzer; --Ed Farina, Pete Gebrian, Bruce Gemmell, Tony Haddad, Ed Kaminski, Mike McVey for their work on an Identification test device in a random access microbiological analyzer; --Pete Gebrian for his work on a Multi-compartment reagent container for containing reagents; --Pete Gebrian for his work on a Canister for inventorying susceptibility test devices in an automated microbiological analyzer; --Jianfang Wang for his work on use of liposomes Liposomes Aqueous compartments enclosed by lipid bilayer membranes; liposomes are also known as lipid vesicles. Phospholipid molecules consist of an elongated nonpolar (hydrophobic) structure with a polar (hydrophilic) structure at one end. of defined composition and size for the preparation of prothrombin time reagents; --Michael Kraus, Carsten Schelp, Wilhelm Schuy for their work on detection and determination of solid phase-associated factors; --Harald Althaus, Hans-Peter Hauser for their work on human procalcitonin and the preparation and use thereof; --Jurgen Patzke, Konrad Braun for their work on a ready-to-use ristocetin cofactor cofactor An atom, organic molecule, or molecular group that is necessary for the catalytic activity (see catalysis) of many enzymes. A cofactor may be tightly bound to the protein portion of an enzyme and thus be an integral part of its functional structure, or it may test reagent possessing long-term stability; --Hermann Pelzer, Werner Stuber for their work on synthetic peptides, antibodies directed against them, and the use thereof; --Hermann Pelzer, Werner Stuber for their work on methods of obtaining antibody directed against prothrombin prothrombin Carbohydrate-protein compound in plasma essential to coagulation. In response to bleeding, a complex series of clotting-factor interactions leads to its conversion by thromboplastin to thrombin, which transforms fibrinogen in plasma into fibrin. fragments F2/F1+2; --Hans-Detlef Dopatka for his work on a washing solution for solid-phase immunometric methods which contains stabilizers for the labeling system and the use thereof; --Robert Ziegelmaier for his work on a one-step immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. for the determination of antigen-specific antibodies of one of the immunoglobulin classes A, M, D or E, and an agent suitable for this purpose. The following patents originated from collaborations with external scientists: --Lutz Gurtler, Eberle Josef, Albrecht v. Brunn, Stefan Knapp, Hans-Peter Hauser for their work on Retrovirus retrovirus, type of RNA virus that, unlike other RNA viruses, reproduces by transcribing itself into DNA. An enzyme called reverse transcriptase allows a retrovirus's RNA to act as the template for this RNA-to-DNA transcription. from the HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. group and its use (4 patents); --Hans-Peter Hauser, Stefan Knapp, Stefan Brust, Lutz Gurtler, Josef Eberle, Lazara Kaptue, Leopold Achengui Zekeng for their work on retrovirus from the HIV type O and its use (MVP-2901/94); --Lutz Gurtler, Hans-Peter Hauser, Deloko Dongmo, Beatrice Yvette, Leopold Zekeng, Lazare Kaptue for their work on Lentivirus lentivirus /len·ti·vi·rus/ (len´ti-vi?rus) any virus of the subfamily Lentivirinae. Lentivirus /Len·ti·vi·rus/ (len´ti-vi?rus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use. With 2003 revenues of more than $1.4 billion, Dade Behring (NASDAQ:DADE) is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the internet at www.dadebehring.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion